Guardant Health Prices $500 Million Convertible Senior Notes Offering
Guardant Health (GH) has announced the pricing of a private offering consisting of $500 million in 0% convertible senior notes due May 15, 2032. The company has also included an option for initial purchasers to acquire up to an additional $50 million in notes, potentially bringing the total offering to $550 million. The move allows Guardant Health to secure significant capital at a zero percent interest rate, providing non-dilutive funding through 2032. This financing is likely intended to support long-term growth initiatives and operational scaling within its liquid biopsy and oncology testing segments.
Tickers: $GH